Department of Pharmacy, Universitas Tadulako, Jl. Soekarno Hatta No.KM. 9, Tondo, Mantikulore, Palu 94148, Indonesia
BibTex Citation Data :
@article{JKSA81803, author = {Shara Wardhani and Saipul Maulana and Jamaluddin Jamaluddin}, title = {In Silico Study of Fatty Acid Compounds in Pure Eel Oil (Anguilla marmorata (Q.) Gaimard) as a Therapeutic Agent for Liver Cancer}, journal = {Jurnal Kimia Sains dan Aplikasi}, volume = {29}, number = {5}, year = {2026}, keywords = {Liver cancer; Eel; network pharmacology; molecular docking; ADMET prediction.}, abstract = { Liver cancer is a leading cause of cancer-related deaths globally, due to late diagnosis and limited treatment options. Developing aquatic resources as sources of bioactive compounds with anti-inflammatory and antiproliferative activities may provide a potential strategy for exploring alternative therapeutic candidates for liver cancer. Eels ( Anguilla marmorata (Q.) Gaimard) are known to contain fatty acids with anti-inflammatory and antiproliferative activities, potentially with anticancer activity. However, there have been no scientific reports related to specific fatty acid compounds in pure eel oil that have the potential to be liver anticancer agents. This study aims to identify the molecular targets of eel oil fatty acids with the potential to inhibit liver cancer cell growth and to analyze molecular interactions and binding affinities with target proteins. The methods used were an integrated computational approach of network pharmacology and molecular docking, accompanied by ADMET prediction. The results of this study showed that network pharmacology analysis predicted three main target proteins, namely SRC, PIK3CA, and PIK3CB, which play an important role in the pathogenesis of liver cancer. The molecular docking results showed that of the 34 eel compounds, six compounds showed strong binding affinity toward SRC, PIK3CA, and PIK3CB, such as 5,8,11,14,17-cis -Eicosapentaenoic Acid (SRC and PIK3CB), Eicosapentaenoic Acid (SRC), Cis-4,7,10,13,16,19 -Docosahexaenoic Acid (SRC, PIK3CA, and PIK3CB), Gamma-Linolenic Acid (PIK3CA), Arachidonic Acid (PIK3CA), and Cis 8,11,14-Eicosatrienoic Acid (PIK3CB). However, these docking scores were weaker than those of the native ligands (approximately −9 to −10 kcal/mol), suggesting relatively weak ATP-binding site occupancy compared with approved inhibitors. ADMET prediction suggested generally favorable ADME properties, and in silico toxicity predictions indicate low acute toxicity risk. In conclusion, this study identified fatty acid compounds from pure eel oil as multi-target therapeutic candidate compounds that may serve as preliminary multi-target candidate compounds for further experimental validation in liver cancer research. }, issn = {2597-9914}, pages = {314--327} doi = {10.14710/jksa.29.5.314-327}, url = {https://ejournal.undip.ac.id/index.php/ksa/article/view/81803} }
Refworks Citation Data :
Liver cancer is a leading cause of cancer-related deaths globally, due to late diagnosis and limited treatment options. Developing aquatic resources as sources of bioactive compounds with anti-inflammatory and antiproliferative activities may provide a potential strategy for exploring alternative therapeutic candidates for liver cancer. Eels (Anguilla marmorata (Q.) Gaimard) are known to contain fatty acids with anti-inflammatory and antiproliferative activities, potentially with anticancer activity. However, there have been no scientific reports related to specific fatty acid compounds in pure eel oil that have the potential to be liver anticancer agents. This study aims to identify the molecular targets of eel oil fatty acids with the potential to inhibit liver cancer cell growth and to analyze molecular interactions and binding affinities with target proteins. The methods used were an integrated computational approach of network pharmacology and molecular docking, accompanied by ADMET prediction. The results of this study showed that network pharmacology analysis predicted three main target proteins, namely SRC, PIK3CA, and PIK3CB, which play an important role in the pathogenesis of liver cancer. The molecular docking results showed that of the 34 eel compounds, six compounds showed strong binding affinity toward SRC, PIK3CA, and PIK3CB, such as 5,8,11,14,17-cis -Eicosapentaenoic Acid (SRC and PIK3CB), Eicosapentaenoic Acid (SRC), Cis-4,7,10,13,16,19 -Docosahexaenoic Acid (SRC, PIK3CA, and PIK3CB), Gamma-Linolenic Acid (PIK3CA), Arachidonic Acid (PIK3CA), and Cis 8,11,14-Eicosatrienoic Acid (PIK3CB). However, these docking scores were weaker than those of the native ligands (approximately −9 to −10 kcal/mol), suggesting relatively weak ATP-binding site occupancy compared with approved inhibitors. ADMET prediction suggested generally favorable ADME properties, and in silico toxicity predictions indicate low acute toxicity risk. In conclusion, this study identified fatty acid compounds from pure eel oil as multi-target therapeutic candidate compounds that may serve as preliminary multi-target candidate compounds for further experimental validation in liver cancer research.
Article Metrics:
Last update:
Last update: 2026-06-18 17:35:11
As an article writer, the author has the right to use their articles for various purposes, including use by institutions that employ authors or institutions that provide funding for research. Author rights are granted without special permission.
Author who publishes a paper at JKSA has the broad right to use their work for teaching and scientific purposes without the need to ask permission, including: used for (i) teaching in the author's class or institution, (ii) presentation at meetings or conferences and distributing copies to participants ; (iii) training conducted by the author or author's institution; (iv) distribution to colleagues for research use; (v) use in the compilation of subsequent authors' works; (vi) inclusion in a thesis or dissertation; (vi) reuse of part of the article in another work (with citation); (vii) preparation of derivative works (with citation); (viii) voluntary posting on open websites operated by authors or author institutions for scientific purposes (follow the CC BY-SA License).
Authors and readers can copy and redistribute material in any media or format, and mix, modify, and build material for any purpose but they must provide appropriate credit (provide article citation or content), providing links to the license, and indicate if there are changes.
The authors submitting a manuscript do so on the understanding that if accepted for publication, copyright of the article shall be assigned to Jurnal Kimia Sains dan Aplikasi (JKSA). Copyright encompasses rights to reproduce and deliver the article in all form and media, including reprints, photographs, microfilms and any other similar reproductions, as well as translations.
Reproduce any part of this journal, its storage in the database or its transmission by all forms or media is permitted does not need for written permission from JKSA. However, it should be cited as an honor in academic manners
JKSA and the Chemistry Department of Diponegoro University and the Editor make every effort to ensure that there are no data, opinions, or false or misleading statements published in JKSA. However, the content of the article is the sole and exclusive responsibility of each author.
The Copyright Transfer Form can be downloaded here: [Copyright Transfer Form - Indonesian] [Copyright Transfer Form - English]. The copyright form should be signed originally and send to the Editor in the form of printed letters, scanned documents sent via email or fax.
Adi Darmawan, Ph.D (Editor in Chief)
Editor in chief of Jurnal Kimia Sains dan Aplikasi (JKSA)
Chemistry Department, Faculty of Sciences and Mathematics, Diponegoro University
Visitor: View My Stats
Jurnal Kimia Sains dan Aplikasi is indexed in:
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
